Developer docs
API playgroundTry for free, no card

Search company profiles

Select Medical Holdings

Full company profile

uuid00qhmds

Namestring
Select Medical Holdings
Legal namestring
Select Medical Holdings Corporation
Company typeenum
Public
Founded yearstring
-
Descriptiontext

Select Medical Holdings Corporation (NYSE: SEM) is one of the largest U.S. operators of post-acute and outpatient rehabilitation facilities, operating 103 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states, and 1,912 outpatient rehabilitation clinics across 37 states and the District of Columbia as of March 31, 2026, for total operations in 38 states plus DC. The company's clinical brands include Select Specialty Hospital, Regency Hospital, Kessler Institute for Rehabilitation, Select Medical Rehabilitation, Select Physical Therapy, NovaCare Rehabilitation, Kessler Rehabilitation Center, KORT Physical Therapy, Champion Sports Medicine, and Banner Physical Therapy, with joint ventures involving Cleveland Clinic, Baylor Scott & White, and Emory. Services span extended acute care for medically complex patients, inpatient rehabilitation for stroke, brain injury, spinal cord injury and orthopedic recovery, and outpatient physical, occupational, and speech therapy across pediatric, sports medicine, and industrial rehabilitation categories.

Revenue is generated through direct hospital and clinic operations reimbursed by Medicare, Medicaid, commercial insurers, workers' compensation, and individual patient arrangements; pricing is not publicly disclosed. Approximately 60% of revenue historically came from the specialty hospitals segment, with the remainder from inpatient rehabilitation and outpatient clinics. In November 2024 the company spun off Concentra Group Holdings Parent, Inc. (NYSE: CON), which operated 2,100+ urgent-care and occupational-health facilities and represented the higher-margin, commercially insured portion of the prior business. Full-year 2025 revenue was $5.45 billion (5.1% YoY) and FY2026 guidance is $5.6-$5.8 billion in revenue with $520-$540 million in adjusted EBITDA.

In March 2026 Select Medical entered a definitive $3.9 billion all-cash take-private agreement at $16.50/share led by Executive Chairman Robert A. Ortenzio, Senior EVP Martin F. Jackson, and Welsh, Carson, Anderson & Stowe, supported by approximately $1 billion in debt financing from JPMorgan Chase and Wells Fargo. Stockholders approved the merger on June 26, 2026 with over 79.88% voting in favor, the HSR waiting period expired April 27, 2026, and the deal is expected to close mid-2026, at which point Select Medical will be delisted from NYSE and exit the S&P SmallCap 600.

Short descriptiontext

Select Medical Holdings operates a national U.S. network of 103 critical illness recovery hospitals, 41 rehabilitation hospitals, and 1,912 outpatient rehabilitation clinics across 38 states plus DC, serving patients requiring post-acute, inpatient rehabilitation, and outpatient therapy services; it is being taken private by WCAS and management for $3.9 billion.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersMechanicsburg, United States
HQ citystring
Mechanicsburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
post-acute care services, critical illness recovery, inpatient rehabilitation, outpatient rehabilitation, specialty hospital operations
Industry3 codes
1Post-Acute Transitional Care / Subacute Rehab Centers
CodeHLADAJANPrimaryYes
2Orthopedic & Post-Surgical Rehabilitation Centers
CodeHLADAJAIPrimaryNo
3Orthopedic & Sports Rehabilitation Centers
CodeHLAFAFAIPrimaryNo
NAICS code2 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals6223
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
SIC code2 codes
  • Services-Hospitals8060
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Post-Acute Healthcare Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Services Revenue
TypeSubscription Recurring
Description

Select Medical generates revenue through operating critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. The company reports approximately 60% of revenue from its specialty hospitals segment. Concentra urgent-care subsidiary operates over 2,100 outpatient facilities representing a high-margin segment with stronger commercial insurance penetration.

finance.yahoo.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Infrastructure, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 10 records shown
1Select Specialty Hospital
Description

Critical illness recovery hospital brand

selectmedical.com
+9 more records
Core offering1 text field

Select Medical Holdings operates a national network of critical illness recovery hospitals, inpatient rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. As of March 31, 2026, the company ran 103 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states, and 1,912 outpatient rehabilitation clinics in 37 states and the District of Columbia. The company provides post-acute medical care and rehabilitative therapy to patients recovering from critical illnesses, strokes, brain injuries, spinal cord injuries, and orthopedic conditions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Revenue growth of 5% year-over-year in Q1 2026 across all three operating divisions
+2 more records
Product overview1 text field

Select Medical Holdings is a healthcare services company operating three core service segments: critical illness recovery hospitals (103 hospitals in 28 states), inpatient rehabilitation hospitals (41 hospitals in 15 states), and outpatient rehabilitation clinics (1,912 clinics in 37 states and DC). The company also maintained Concentra as an urgent care subsidiary until its November 2024 spin-off. The hospital brands include Select Specialty Hospital, Regency Hospital, Kessler Institute for Rehabilitation, and joint ventures with health systems such as Cleveland Clinic, Baylor Scott & White, and Emory. Outpatient services are delivered under brands including Select Physical Therapy, NovaCare Rehabilitation, Kessler Rehabilitation Center, KORT Physical Therapy, and Champion Sports Medicine, with pediatric therapy offered through Select Kids, NovaCare Kids, and Harmony Pediatric Therapy. The company was taken private via a $3.9 billion acquisition by a consortium led by Executive Chairman Robert A. Ortenzio and Welsh, Carson, Anderson & Stowe, with closing expected mid-2026.

Product and service1 record
1Critical Illness Recovery Hospitals
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Concentra was spun off from Select Medical as a separate publicly traded company (NYSE: CON) in November 2024. Concentra operates over 2,100 urgent-care and occupational health outpatient facilities and represented a strategically valuable high-margin segment with stronger commercial insurance penetration.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Encompass Health is the largest pure-play operator of inpatient rehabilitation hospitals in the U.S., directly comparable to Select Medical's 41 IRFs and competing for Medicare rehab discharges from the same acute-care referral base.

TypeBroad incumbent
Description

Acadia is a publicly traded specialty hospital operator (behavioral health); comparable as a publicly traded specialty inpatient platform with similar CMS reimbursement exposure and growth-by-de-novo strategy.

TypeBroad incumbent
Description

Tenet operates acute-care hospitals and ambulatory surgery networks with significant post-acute and outpatient service exposure; comparable as a multi-segment U.S. healthcare services operator with Medicare-skewed revenue mix.

TypeBroad incumbent
Description

HCA is the largest U.S. for-profit hospital system; it discharges a meaningful share of patients into Select Medical's specialty and rehab hospitals and competes for inpatient post-acute capacity in shared geographies.

TypeEmerging player
Description

Surgery Partners is a specialty outpatient facility operator (ambulatory surgery centers); overlaps with Select Medical's outpatient strategy and post-surgical rehabilitation referral pipeline but on the surgical side.

TypeBroad incumbent
Description

UHS operates acute-care and behavioral health hospitals nationwide; its acute-care footprint generates the inpatient referrals that feed Select Medical's rehab and critical illness recovery hospitals.

TypeDirect peer
Description

Enhabit was spun off from Encompass Health in 2022 as a home health and hospice operator; it competes with Select Medical for post-discharge patients and overlaps in the broader post-acute care continuum.

TypeEmerging player
Description

Aveanna provides home health and private duty nursing services, comparable as a post-acute and home/community-based care provider that competes for the same discharged patient population as Select Medical.

TypeDirect peer
Description

U.S. Physical Therapy operates ~650 outpatient physical therapy clinics, directly comparable to Select Medical's 1,912-clinic outpatient rehab segment in terms of therapy services, payor mix, and clinic economics.

TypeDirect peer
Description

Ensign operates skilled nursing and post-acute rehabilitation facilities across the U.S., overlapping with Select Medical's critical illness recovery hospitals and outpatient rehab clinics in caring for medically complex post-acute patients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Select Medical Holdings

Post-Acute Healthcare Servicesselectmedicalholdings.com

Select Medical Holdings operates a national U.S. network of 103 critical illness recovery hospitals, 41 rehabilitation hospitals, and 1,912 outpatient rehabilitation clinics across 38 states plus DC, serving patients requiring post-acute, inpatient rehabilitation, and outpatient therapy services; it is being taken private by WCAS and management for $3.9 billion.

What Select Medical Holdings does

Select Medical Holdings Corporation (NYSE: SEM) is one of the largest U.S. operators of post-acute and outpatient rehabilitation facilities, operating 103 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states, and 1,912 outpatient rehabilitation clinics across 37 states and the District of Columbia as of March 31, 2026, for total operations in 38 states plus DC. The company's clinical brands include Select Specialty Hospital, Regency Hospital, Kessler Institute for Rehabilitation, Select Medical Rehabilitation, Select Physical Therapy, NovaCare Rehabilitation, Kessler Rehabilitation Center, KORT Physical Therapy, Champion Sports Medicine, and Banner Physical Therapy, with joint ventures involving Cleveland Clinic, Baylor Scott & White, and Emory. Services span extended acute care for medically complex patients, inpatient rehabilitation for stroke, brain injury, spinal cord injury and orthopedic recovery, and outpatient physical, occupational, and speech therapy across pediatric, sports medicine, and industrial rehabilitation categories.

Revenue is generated through direct hospital and clinic operations reimbursed by Medicare, Medicaid, commercial insurers, workers' compensation, and individual patient arrangements; pricing is not publicly disclosed. Approximately 60% of revenue historically came from the specialty hospitals segment, with the remainder from inpatient rehabilitation and outpatient clinics. In November 2024 the company spun off Concentra Group Holdings Parent, Inc. (NYSE: CON), which operated 2,100+ urgent-care and occupational-health facilities and represented the higher-margin, commercially insured portion of the prior business. Full-year 2025 revenue was $5.45 billion (5.1% YoY) and FY2026 guidance is $5.6-$5.8 billion in revenue with $520-$540 million in adjusted EBITDA.

In March 2026 Select Medical entered a definitive $3.9 billion all-cash take-private agreement at $16.50/share led by Executive Chairman Robert A. Ortenzio, Senior EVP Martin F. Jackson, and Welsh, Carson, Anderson & Stowe, supported by approximately $1 billion in debt financing from JPMorgan Chase and Wells Fargo. Stockholders approved the merger on June 26, 2026 with over 79.88% voting in favor, the HSR waiting period expired April 27, 2026, and the deal is expected to close mid-2026, at which point Select Medical will be delisted from NYSE and exit the S&P SmallCap 600.

Select Medical Holdings firmographics

Firmographics
Name
Select Medical Holdings
Legal name
Select Medical Holdings Corporation
Website
https://selectmedicalholdings.com
Company type
Public
Operating status
Acquired
Headcount range
5,001–10,000 employees
Short description
Select Medical Holdings operates a national U.S. network of 103 critical illness recovery hospitals, 41 rehabilitation hospitals, and 1,912 outpatient rehabilitation clinics across 38 states plus DC, serving patients requiring post-acute, inpatient rehabilitation, and outpatient therapy services; it is being taken private by WCAS and management for $3.9 billion.
Ownership category
akta.pro rank

Select Medical Holdings industry classification

Industry
Product category
Post-Acute Healthcare Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
SIC
Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Post-Acute Transitional Care / Subacute Rehab Centers (HLADAJAN)
akta.pro secondary industries
Orthopedic & Post-Surgical Rehabilitation Centers (HLADAJAI), Orthopedic & Sports Rehabilitation Centers (HLAFAFAI)

Keywords

  • Post-acute care services
  • Critical illness recovery
  • Inpatient rehabilitation
  • Outpatient rehabilitation
  • Specialty hospital operations

Where Select Medical Holdings is headquartered

Location

Headquarters

HQ city
Mechanicsburg
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Select Medical Holdings business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Supply Chain

Revenue model

  1. Healthcare Services Revenue: Select Medical generates revenue through operating critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. The company reports approximately 60% of revenue from its specialty hospitals segment. Concentra urgent-care subsidiary operates over 2,100 outpatient facilities representing a high-margin segment with stronger commercial insurance penetration.

Go-to-market motion1 record

Distribution channels1 record

Select Medical Holdings product offering

Product offering

Core offering

Select Medical Holdings operates a national network of critical illness recovery hospitals, inpatient rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. As of March 31, 2026, the company ran 103 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states, and 1,912 outpatient rehabilitation clinics in 37 states and the District of Columbia. The company provides post-acute medical care and rehabilitative therapy to patients recovering from critical illnesses, strokes, brain injuries, spinal cord injuries, and orthopedic conditions.

Product overview

Select Medical Holdings is a healthcare services company operating three core service segments: critical illness recovery hospitals (103 hospitals in 28 states), inpatient rehabilitation hospitals (41 hospitals in 15 states), and outpatient rehabilitation clinics (1,912 clinics in 37 states and DC). The company also maintained Concentra as an urgent care subsidiary until its November 2024 spin-off. The hospital brands include Select Specialty Hospital, Regency Hospital, Kessler Institute for Rehabilitation, and joint ventures with health systems such as Cleveland Clinic, Baylor Scott & White, and Emory. Outpatient services are delivered under brands including Select Physical Therapy, NovaCare Rehabilitation, Kessler Rehabilitation Center, KORT Physical Therapy, and Champion Sports Medicine, with pediatric therapy offered through Select Kids, NovaCare Kids, and Harmony Pediatric Therapy. The company was taken private via a $3.9 billion acquisition by a consortium led by Executive Chairman Robert A. Ortenzio and Welsh, Carson, Anderson & Stowe, with closing expected mid-2026.

Differentiator

Problem solved

Functional benefit

Brands

  • Select Specialty Hospital: Critical illness recovery hospital brand
  • Regency Hospital
  • Select Medical Rehabilitation
  • Kessler Institute for Rehabilitation
  • Select Physical Therapy
  • NovaCare Rehabilitation
  • Kessler Rehabilitation Center
  • KORT Physical Therapy
  • Champion Sports Medicine
  • Banner Physical Therapy

Products and services

  • Critical Illness Recovery Hospitals

Quantifiable outcome

  • Revenue growth of 5% year-over-year in Q1 2026 across all three operating divisions
  • +2 more outcomes

Companies that use Select Medical Holdings

Customer profile

Segments2 records

Ideal customer profiles2 records

Select Medical Holdings technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Select Medical Holdings partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Concentra Group Holdings Parent, Inc.minorStrategic or Co-development PartnerConcentra was spun off from Select Medical as a separate publicly traded company (NYSE: CON) in November 2024. Concentra operates over 2,100 urgent-care and occupational health outpatient facilities and represented a strategically valuable high-margin segment with stronger commercial insurance penetration.

Scale indicators8 records

Recent moves8 records

Expansion highlights4 records

Select Medical Holdings competitors and assessment

Company assessment

Direct peers

  • Encompass Health Corporation: Encompass Health is the largest pure-play operator of inpatient rehabilitation hospitals in the U.S., directly comparable to Select Medical's 41 IRFs and competing for Medicare rehab discharges from the same acute-care referral base.
  • Enhabit Inc. Enhabit was spun off from Encompass Health in 2022 as a home health and hospice operator; it competes with Select Medical for post-discharge patients and overlaps in the broader post-acute care continuum.
  • U.S. Physical Therapy, Inc. U.S. Physical Therapy operates ~650 outpatient physical therapy clinics, directly comparable to Select Medical's 1,912-clinic outpatient rehab segment in terms of therapy services, payor mix, and clinic economics.
  • The Ensign Group, Inc. Ensign operates skilled nursing and post-acute rehabilitation facilities across the U.S., overlapping with Select Medical's critical illness recovery hospitals and outpatient rehab clinics in caring for medically complex post-acute patients.

Broad incumbents

  • Acadia Healthcare Company, Inc. Acadia is a publicly traded specialty hospital operator (behavioral health); comparable as a publicly traded specialty inpatient platform with similar CMS reimbursement exposure and growth-by-de-novo strategy.
  • Tenet Healthcare Corporation: Tenet operates acute-care hospitals and ambulatory surgery networks with significant post-acute and outpatient service exposure; comparable as a multi-segment U.S. healthcare services operator with Medicare-skewed revenue mix.
  • HCA Healthcare, Inc. HCA is the largest U.S. for-profit hospital system; it discharges a meaningful share of patients into Select Medical's specialty and rehab hospitals and competes for inpatient post-acute capacity in shared geographies.
  • Universal Health Services, Inc. UHS operates acute-care and behavioral health hospitals nationwide; its acute-care footprint generates the inpatient referrals that feed Select Medical's rehab and critical illness recovery hospitals.

Emerging players

  • Surgery Partners, Inc. Surgery Partners is a specialty outpatient facility operator (ambulatory surgery centers); overlaps with Select Medical's outpatient strategy and post-surgical rehabilitation referral pipeline but on the surgical side.
  • Aveanna Healthcare Holdings: Aveanna provides home health and private duty nursing services, comparable as a post-acute and home/community-based care provider that competes for the same discharged patient population as Select Medical.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Select Medical Holdings social profiles

Digital presence

Select Medical Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Select Medical Holdings leadership team

Management profile

Number of profiles

Profiles2 records

Select Medical Holdings subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Select Medical Holdings funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Select Medical Holdings M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Select Medical Holdings

What does Select Medical Holdings do?

Select Medical Holdings operates a national network of critical illness recovery hospitals, inpatient rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. As of March 31, 2026, the company ran 103 critical illness recovery hospitals in 28 states, 41 rehabilitation hospitals in 15 states, and 1,912 outpatient rehabilitation clinics in 37 states and the District of Columbia. The company provides post-acute medical care and rehabilitative therapy to patients recovering from critical illnesses, strokes, brain injuries, spinal cord injuries, and orthopedic conditions.

Is Select Medical Holdings a public or private company?

Select Medical Holdings is a public company. It is classified as private equity controlled and is currently acquired.

When was Select Medical Holdings founded?

Select Medical Holdings was founded in -1. It employs 5,001 to 10,000 people.

Where is Select Medical Holdings based?

Select Medical Holdings is headquartered in Mechanicsburg, United States, in the North America region.

How does Select Medical Holdings make money?

One revenue line is on record: healthcare Services Revenue.

Who are Select Medical Holdings's main competitors?

Direct peers on record are Encompass Health Corporation, Enhabit Inc., U.S. Physical Therapy, Inc. and The Ensign Group, Inc.. Broad incumbents are Acadia Healthcare Company, Inc., Tenet Healthcare Corporation, HCA Healthcare, Inc. and Universal Health Services, Inc.. Emerging players are Surgery Partners, Inc. and Aveanna Healthcare Holdings.

Does Select Medical Holdings have an API?

No public API is recorded for Select Medical Holdings.

What industry is Select Medical Holdings in?

Select Medical Holdings's product category is Post-Acute Healthcare Services. Its primary akta.pro industry code is HLADAJAN, Post-Acute Transitional Care / Subacute Rehab Centers, with a secondary code of HLADAJAI, Orthopedic & Post-Surgical Rehabilitation Centers. Its NAICS code is 6223 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FortunebusinessinsightsPhysiotherapy Services Market Size, Share and Growth 2034The global physiotherapy services market is projected to grow from USD 68.72 billion in 2026 to USD 111.20 billion by 2034, driven by rising demand for pain management and rehabilitation among aging populations. Key industry players such as U.S. Physical Therapy, Select Medical Holdings Corporation, and Encompass Health Corporation are actively expanding through acquisitions and strategic partnerships to increase service access and network coverage.FierceHealthcareHealthcare Dealmakers—Ascension closes $3.9B Amsurg purchase, Hims & Hers' $1.2B international play and moreThis article provides a roundup of healthcare mergers and acquisitions activity during June, covering provider systems, payers, and health tech companies. Major deals include Ascension's $3.9 billion acquisition of ambulatory surgery center operator AmSurg, making it the country's third-largest ASC platform with over 300 locations, and Select Medical Holdings' $3.9 billion go-private transaction led by Welsh, Carson, Anderson & Stowe. In the tech sector, Hims & Hers completed its planned $1.2 billion acquisition of Australian digital health company Eucalyptus, marking a significant international expansion for the D2C health platform.The Philadelphia InquirerNovaCare Rehabilitation’s parent, Select Medical, was sold in $3.9 billion private equity dealSelect Medical Holdings Corp. was taken private in a $3.9 billion private equity deal, with top management joining Welsh, Carson, Anderson & Stowe. NovaCare, a subsidiary, operates over 100 physical therapy locations in the Philadelphia region. The deal was completed Wednesday at $16.50 per share, an 18% premium.Pulse 2.0Select Medical Being Acquired By Ortenzio, Jackson, And WCAS Consortium For $3.9 BillionSelect Medical Holdings has been acquired by a consortium affiliated with Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe for approximately $3.9 billion, with the transaction becoming effective on July 1, 2026. The $16.50 per share purchase price represented a premium of approximately 18% over Select Medical's unaffected share price as of November 24, 2025, and approximately 25% over the 90-day volume-weighted average closing share price, causing Select Medical's common stock to cease trading on the New York Stock Exchange. Following the closing, Select Medical's current officers including Ortenzio and Jackson will continue to lead the business in their respective roles.citybizSelect Medical Completes $3.9 Billion Acquisition by Investor ConsortiumSelect Medical Holdings has completed its acquisition by a consortium led by Executive Chairman Robert Ortenzio, Senior Executive Vice President Martin Jackson, and private equity firm Welsh, Carson, Anderson & Stowe (WCAS) for approximately $3.9 billion. Shareholders received $16.50 per share in cash, representing an 18% premium over the unaffected closing share price and a 25% premium over the 90-day volume-weighted average share price. Following the merger's effectiveness on July 1, Select Medical's common stock has ceased trading on the New York Stock Exchange, with the consortium now holding majority economic interest and operational control of the business.AijournSelect Medical Holdings Corporation Acquired by Consortium Led by Robert A. Ortenzio, Martin F. Jackson, and WCASSelect Medical Holdings Corporation has completed its acquisition by a consortium led by Executive Chairman Robert A. Ortenzio, Senior Executive Vice President Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS) for $16.50 per share, valuing the company at approximately $3.9 billion. The acquisition represents a premium of approximately 18% over Select Medical's unaffected share price as of November 24, 2025, and approximately 25% over its 90-day volume-weighted average closing share price. Stockholders approved the transaction on June 26, 2026, and the company ceased trading and delisted from the New York Stock Exchange on July 1, 2026, with the current management team continuing to lead the business.PR NewswireSelect Medical Holdings Corporation Acquired by Consortium Led by Robert A. Ortenzio, Martin F. Jackson, and WCASSelect Medical Holdings Corporation has been acquired by a consortium led by its Executive Chairman and Co-Founder Robert A. Ortenzio, Senior Executive Vice President Martin F. Jackson, and private equity firm Welsh, Carson, Anderson & Stowe (WCAS), with the acquisition becoming effective July 1, 2026. The deal valued the company at approximately $3.9 billion, representing a $16.50 per share purchase price that reflects a premium of approximately 18% over the unaffected share price as of November 24, 2025. Following the closing, Select Medical's common stock will cease trading on the NYSE, and the company's leadership including Ortenzio and Jackson will continue in their respective roles.Stock TitanSelect Medical acquisition closes at $16.50 a shareSelect Medical Holdings Corporation has been acquired by a consortium led by Robert A. Ortenzio and Welsh, Carson, Anderson & Stowe at $16.50 per share, with the transaction valued at approximately $3.9 billion and completed on June 30, 2026. Select Medical's common stock will cease trading and be delisted from the New York Stock Exchange as of July 1, 2026, with the company's current leadership continuing to operate the business under the new ownership structure. The purchase price represents a premium of approximately 18% over Select Medical's unaffected share price as of November 24, 2025, and was approved by stockholders at a special meeting on June 26, 2026.BitgetSelect Medical Holdings Corporation announced that its shareholders have officially approved the tender offer initiated by a consortium composed of company executives Robert A. Ortenzio, Martin F. JacSelect Medical Holdings Corporation shareholders have officially approved a tender offer from a consortium comprising company executives Robert A. Ortenzio and Martin F. Jackson, along with private equity firm Welsh, Carson, Anderson & Stowe (WCAS). The resolution represents a significant step toward taking the healthcare service provider private, with Select Medical set to be delisted from public markets upon transaction completion.AijournSelect Medical Holdings Corporation Announces Stockholder Approval of Acquisition by Consortium Led by Robert A. Ortenzio, Martin F. Jackson, and WCASSelect Medical Holdings Corporation announced that its stockholders approved the proposed merger with a consortium led by Co-Founder Robert A. Ortenzio, Senior Executive Vice President Martin F. Jackson, and private equity firm Welsh, Carson, Anderson & Stowe (WCAS) at a special meeting on June 26, 2026. Approximately 82.54% of outstanding shares voted, with over 79.88% approving the merger and over 76.64% of unaffiliated stockholders voting in favor. The transaction remains subject to closing conditions and is expected to finalize mid-2026.